
================================================================================
=== DOCUMENT 1: 8-K - ahr-20250625.htm ===
================================================================================

ahr-20250625
FALSE
0001632970
0001632970
2025-06-25
2025-06-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
June 25, 2025
American Healthcare REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland
001-41951
47-2887436
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
18191 Von Karman Avenue
,
Suite 300
Irvine
,
California
92612
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(
949
)
270-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
AHR
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 25, 2025, we held our 2025 Annual Meeting of Stockholders. At the meeting, our stockholders voted on the following four proposals: (i) to consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2026 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies; (ii) to consider and vote upon the ratification of the appointment of Deloitte & Touche LLP, or Deloitte & Touche, as our independent registered public accounting firm for the year ending December 31, 2025; (iii) to approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2024; and (iv) to approve the American Healthcare REIT, Inc. 2025 Manager Equity Plan. The four proposals are described in detail in our definitive proxy statement, dated April 10, 2025, as filed with the United States Securities and Exchange Commission on Schedule 14A on April 10, 2025.
The votes with respect to each of the proposals are set forth below.
Proposal 1.   To consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2026 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies:
Nominee
Shares For
Shares Withheld
Broker Non-Votes
Jeffrey T. Hanson
110,491,724
6,780,802
22,564,319
Danny Prosky
116,312,997
959,529
22,564,319
Mathieu B. Streiff
111,148,837
6,123,689
22,564,319
Scott A. Estes
116,035,501
1,237,025
22,564,319
Brian J. Flornes
100,685,107
16,587,419
22,564,319
Dianne Hurley
115,425,541
1,846,985
22,564,319
Marvin R. O'Quinn
116,676,785
595,741
22,564,319
Valerie Richardson
114,471,250
2,801,276
22,564,319
Wilbur H. Smith III
113,438,464
3,834,062
22,564,319
The nine above-referenced nominees therefore were elected as our directors by the requisite vote of our stockholders necessary for approval.
Proposal 2.  To consider and vote upon the ratification of the appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2025:
Shares For
Shares Against
Shares Abstained
138,414,959
1,139,417
282,469
The appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2025, therefore was ratified by the requisite vote of our stockholders necessary for approval.
Proposal 3.   To approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2024:
Shares For
Shares Against
Shares Abstained
Broker Non-Votes
109,297,003
7,525,316
450,207
22,564,319
The compensation of our named executive officers therefore was approved by the requisite vote of our stockholders, on an advisory basis.
Proposal 4.   To approve the American Healthcare REIT, Inc. 2025 Manager Equity Plan:
Shares For
Shares Against
Shares Abstained
Broker Non-Votes
112,586,838
4,273,480
412,208
22,564,319
The American Healthcare REIT, Inc. 2025 Manager Equity Plan
therefore was approved by the requisite vote of our stockholders
.
No other proposals were submitted to a vote of our stockholders at the annual meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
American Healthcare REIT, Inc.
June 26, 2025
By:
/s/ Danny Prosky
Name: Danny Prosky
Title: Chief Executive Officer and President

